Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2001, p. 1746-1750, Vol. 45, No. 6
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.6.1746-1750.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In Vitro Activities of Antibiotics against
Plasmodium falciparum Are Inhibited by Iron
Bruno
Pradines,*
Christophe
Rogier,
Thierry
Fusai,
Joel
Mosnier,
William
Daries,
Eric
Barret, and
Daniel
Parzy
Unité de Parasitologie, Institut de
Médecine Tropicale du Service de Santé des
Armées, Le Pharo, 13998 Marseille, France
Received 12 January 2001/Returned for modification 20 February
2001/Accepted 19 March 2001
The in vitro activities of cyclines (tetracycline,
doxycycline, minocycline, oxytetracycline, and rolitetracycline),
macrolides (erythromycin, spiramycin, roxithromycin, and
lincomycin), quinolones (norfloxacin and ofloxacin), rifampin,
thiamphenicol, tobramycin, metronidazole, vancomycin, phosphomycin, and
cephalosporins (cephalexin, cefaclor, cefamandole, cefuroxime,
ceftriazone, cefotaxime, and cefoxitin) were evaluated on
Plasmodium falciparum clones, using an isotopic,
micro-drug susceptibility test. Only tetracyclines, macrolides,
quinolones, and rifampin demonstrated in vitro activity against
P. falciparum, which increased after a prolonged exposure (96 or 144 h). In the presence of iron (FeCl3), only
the activities of tetracyclines and norfloxacin were decreased. Their
in vitro activity against intraerythrocytic stages of
multidrug-resistant P. falciparum and their efficacy in
vivo favor the use of antibiotics as antimalarial drugs. However, due
to their slow antimalarial action and to the fact that they act better
after prolonged contact, they probably need to be administered in
conjunction with a rapidly acting antimalarial drug, such as a short
course of chloroquine or quinine.
*
Corresponding author. Mailing address: IMTSSA,
Unité de Parasitologie, Bd Charles Livon, Parc le Pharo, BP 46, 13998 Marseille Armées, France. Phone: 33 4 91 15 01 10. Fax: 33 4 91 15 01 64. E-mail: bruno.pradines{at}free.fr.
Antimicrobial Agents and Chemotherapy, June 2001, p. 1746-1750, Vol. 45, No. 6
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.6.1746-1750.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Briolant, S., Baragatti, M., Parola, P., Simon, F., Tall, A., Sokhna, C., Hovette, P., Mamfoumbi, M. M., Koeck, J.-L., Delmont, J., Spiegel, A., Castello, J., Gardair, J. P., Trape, J. F., Kombila, M., Minodier, P., Fusai, T., Rogier, C., Pradines, B.
(2009). Multinormal In Vitro Distribution Model Suitable for the Distribution of Plasmodium falciparum Chemosusceptibility to Doxycycline. Antimicrob. Agents Chemother.
53: 688-695
[Abstract]
[Full Text]
-
Dahl, E. L., Rosenthal, P. J.
(2007). Multiple Antibiotics Exert Delayed Effects against the Plasmodium falciparum Apicoplast. Antimicrob. Agents Chemother.
51: 3485-3490
[Abstract]
[Full Text]
-
Prasad, T., Chandra, A., Mukhopadhyay, C. K., Prasad, R.
(2006). Unexpected Link between Iron and Drug Resistance of Candida spp.: Iron Depletion Enhances Membrane Fluidity and Drug Diffusion, Leading to Drug-Susceptible Cells. Antimicrob. Agents Chemother.
50: 3597-3606
[Abstract]
[Full Text]
-
Dahl, E. L., Shock, J. L., Shenai, B. R., Gut, J., DeRisi, J. L., Rosenthal, P. J.
(2006). Tetracyclines Specifically Target the Apicoplast of the Malaria Parasite Plasmodium falciparum.. Antimicrob. Agents Chemother.
50: 3124-3131
[Abstract]
[Full Text]
-
Pradines, B., Tall, A., Ramiandrasoa, F., Spiegel, A., Sokhna, C., Fusai, T., Mosnier, J., Daries, W., Trape, J. F., Kunesch, G., Parzy, D., Rogier, C.
(2006). In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum. J Antimicrob Chemother
57: 1093-1099
[Abstract]
[Full Text]
-
Leon-Sicairos, N., Lopez-Soto, F., Reyes-Lopez, M., Godinez-Vargas, D., Ordaz-Pichardo, C., de la Garza, M.
(2006). Amoebicidal Activity of Milk, Apo-lactoferrin, sIgA and Lysozyme.. Clin Med Res
4: 106-113
[Abstract]
[Full Text]
-
Avery, A. M., Goddard, H. J., Sumner, E. R., Avery, S. V.
(2004). Iron Blocks the Accumulation and Activity of Tetracyclines in Bacteria. Antimicrob. Agents Chemother.
48: 1892-1894
[Abstract]
[Full Text]
-
Mahmoudi, N., Ciceron, L., Franetich, J.-F., Farhati, K., Silvie, O., Eling, W., Sauerwein, R., Danis, M., Mazier, D., Derouin, F.
(2003). In Vitro Activities of 25 Quinolones and Fluoroquinolones against Liver and Blood Stage Plasmodium spp.. Antimicrob. Agents Chemother.
47: 2636-2639
[Abstract]
[Full Text]
-
Pradines, B., Rolain, J. M., Ramiandrasoa, F., Fusai, T., Mosnier, J., Rogier, C., Daries, W., Baret, E., Kunesch, G., Le Bras, J., Parzy, D.
(2002). Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum. J Antimicrob Chemother
50: 177-187
[Abstract]
[Full Text]
-
Emerson, L. R., Nau, M. E., Martin, R. K., Kyle, D. E., Vahey, M., Wirth, D. F.
(2002). Relationship between Chloroquine Toxicity and Iron Acquisition in Saccharomyces cerevisiae. Antimicrob. Agents Chemother.
46: 787-796
[Abstract]
[Full Text]
-
Pradines, B., Ramiandrasoa, F., Rolain, J. M., Rogier, C., Mosnier, J., Daries, W., Fusai, T., Kunesch, G., Le Bras, J., Parzy, D.
(2002). In Vitro Potentiation of Antibiotic Activities by a Catecholate Iron Chelator against Chloroquine-Resistant Plasmodium falciparum. Antimicrob. Agents Chemother.
46: 225-228
[Abstract]
[Full Text]